DYN
Dyne Therapeutics, Inc.
+0.50 (+2.86%)17.80USD1.1M成交股數3.3B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 152M | 101M | 95.4M | 97.2M | 99.2M | 106M | 92.8M | 62.3M | 44.5M | 58.8M | 55.3M | 59.1M |
| 銷售管理費用 | 29.5M | 24.4M | 20.7M | 16.7M | 16.6M | 15.9M | 12.9M | 9.7M | 24.6M | 8.8M | 7.0M | 7.6M |
| 營業利益 | −182M+57% | −125M+2% | −116M+10% | −114M+58% | −116M+67% | −122M+81% | −106M+70% | −72.0M+8% | −69.2M | −67.7M | −62.3M | −66.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −179M+61% | −121M+5% | 334M-444% | −108M+66% | −111M+69% | −115M-168% | −97.1M+61% | −65.1M+0% | −65.6M | 169M | −60.2M | −64.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.08+11% | -0.73-30% | -0.69-28% | -0.76+9% | -0.97+20% | -1.05-5% | -0.96-3% | -0.70-35% | -0.81 | -1.10 | -0.99 | -1.08 |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 676M | 753M | 893M | 574M | 485M | 472M | 532M | 608M | 272M | 122M | 130M | 168M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 994M | 1.1B | 1.2B | 867M | 729M | 721M | 769M | 826M | 522M | 165M | 205M | 251M |
| 有息負債 | 199M | 149M | 149M | 99.1M | 98.8M | – | – | – | – | – | – | – |
| 總負債 | 292M | 215M | 215M | 175M | 158M | 52.1M | 63.3M | 50.7M | 44.2M | 73.8M | 53.2M | 44.5M |
| 股東權益 | 702M | 865M | 972M | 692M | 571M | 669M | 706M | 775M | 478M | 91.3M | 152M | 207M |
| 負債比 | 29.4% | 19.9% | 18.1% | 20.2% | 21.6% | 7.2% | 8.2% | 6.1% | 8.5% | 44.7% | 25.9% | 17.7% |
| 淨現金(現金 − 有息負債) | 477M | 604M | 744M | 474M | 386M | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −145M+37% | – | – | – | −106M | – | – | −78.5M | – | – | – |
| 資本支出 | – | 221K | – | – | – | 981K | – | – | 191K | – | – | – |
| 自由現金流 | – | −145M+36% | – | – | – | −107M | – | – | −78.7M | – | – | – |
| 折舊攤銷 | 600K | 550K | 547K | 500K | 500K | 502K | 400K | 400K | 386K | 461K | 400K | 400K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −446.20 | –% | -3.47 | −405M |
| FY2024 | – | – | −317.40 | –% | -3.37 | −295M |
| FY2023 | – | – | −235.90 | –% | -3.95 | −189M |
| FY2022 | – | – | −168.10 | –% | -3.23 | −157M |
| FY2021 | – | – | −149M | –% | -2.93 | −123M |
| FY2020 | – | – | −59.4M | –% | -4.13 | −47.7M |
| FY2019 | – | – | −14.9M | –% | -6.08 | −13.5M |